iRadimed Corp (IRMD)

HEALTH CARE: HEALTH CARE SUPPLIES
SIC: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

1025 WILLA SPRINGS DR. WINTER SPRINGS, FL 32708

iRadimed Corp provides non-magnetic intravenous infusion pump systems for use during magnetic resonance imaging procedures.

Data as of 2020-08-01
Market Cap268.474 Million Shares Outstanding12.05 Million Avg 30-day Volume56.6 Thousand
P/E Ratio30.2 Dividend Yield EPS0.77
Price/Sales9.091 Price cash flow ratio26.6 Price free cash flow ratio35.6
Book Value4.82 Price to Tangible Book4.91 Alpha0.0
Short Interest Ratio % Short Interest to Float R-squared0.13054
BETA1.31255 52-week High/Low28.43 / 14.415 Stddev0.156302
View SEC Filings from IRMD instead.
Q1 2020 All Institutions Hedge Funds 1
Filers who had this stock in their top 10: 2 1 (0.07%)
13F Filers holding this stock: 70 26 (1.7%)
Aggregate 13F shares on 03/31/2020: 4.082 Million 2.17 Million
Aggregate 13F shares on 12/31/2019: 3.691 Million 1.686 Million
Percent change: 10.60% 28.69%
Funds creating new positions: 11 5
Funds Adding to an existing position: 20 11
Funds closing out their position: 5 4
Funds reducing their position: 28 7
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding IRMD (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding IRMD BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

9.1 Thousand total shares from 1 transactions

Exercise Derivative Conversion (M)

6.4 Thousand total shares from 2 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

ALLEN MONTY K

12,221 2020-08-06 5

SUSI ROGER E. PRESIDENT, CEO, AND CHAIRMAN

5,731,050 2020-07-28 3

WALDMAN LOUIS S.

  • FORMER CONTROLLER
38,901 2020-07-24 6

HAWKINS JAMES B

  • Director
128,082 2020-07-20 2

MCDONNELL LESLIE L

  • FORMER CEO & DIRECTOR
121,333 2020-05-28 5

JOHNSON BRENT EXEC. VP OF WW SALES AND MKTG

3,663 2020-04-09 47

NARDI STEVEN M. VP MANUFACTURING

0 2020-02-20 6

KENNEDY JONATHAN PRESIDENT AND CEO

  • Officer
  • Director
161,599 2020-01-10 0

MCCREERY JOHN K CHIEF OPERATING OFFICER

43,315 2020-01-06 3

SCOTT CHRISTOPHER K. CFO & SECRETARY

21,032 2019-12-31 4

CASEY FRANCIS X. VP OF REG. AND QUAL. ASSURANCE

53,474 2019-12-31 4

VUOTO ANTHONY

16,340 2019-12-10 4

NOVOVICH SERGE

  • Director
104,636 2016-02-19 0

SUSI ROGER E. CEO, PRESIDENT

PHILLIP SUSI 2008 DYNASTY TRUST

MATTHEW SUSI 2008 DYNASTY TRUST

ROGER E. SUSI REVOCABLE TRUST

  • Officer
  • Director
  • 10% Owner
4,637,500 2014-07-15 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

ALLEN MONTY K

2020-08-06 S 9,062 $22.22 d 12,221 12,221.00 direct

SUSI ROGER E. PRESIDENT, CEO, AND CHAIRMAN by roger e. susi revocable trust

2020-07-28 G 30,500 d 985,050 5,731,050.00 indirect

WALDMAN LOUIS S. FORMER CONTROLLER

2020-07-24 M 1,476 d 0 38,901.00 direct

WALDMAN LOUIS S. FORMER CONTROLLER

2020-07-24 M 5,155 a 40,155 38,901.00 direct

WALDMAN LOUIS S. FORMER CONTROLLER

2020-07-24 M 1,748 d 0 38,901.00 direct

WALDMAN LOUIS S. FORMER CONTROLLER

2020-07-24 M 750 d 0 38,901.00 direct

WALDMAN LOUIS S. FORMER CONTROLLER

2020-07-24 M 1,181 d 0 38,901.00 direct

WALDMAN LOUIS S. FORMER CONTROLLER

2020-07-24 F 1,254 $23.47 d 38,901 38,901.00 direct

HAWKINS JAMES B

2020-06-26 M 1,268 a 13,815 13,815.00 direct

HAWKINS JAMES B

2020-06-26 M 1,268 d 1,268 13,815.00 direct
Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments